Cryo Cell International (CCEL) Cost of Revenue (2010 - 2026)

Cryo Cell International has disclosed Cost of Revenue across 17 years of filings, most recently posting $1.7 million for Q1 2026.

• In Q1 2026, Cost of Revenue fell 16.53% year-over-year to $1.7 million; the TTM figure through Feb 2026 stood at $7.0 million (down 9.31% YoY), while the FY2025 annual figure was $7.4 million, down 7.19% from the prior year.
• Cost of Revenue declined to $1.7 million in Q1 2026, from $1.7 million in the prior quarter.
• Over the last five years, Cost of Revenue for CCEL reached as high as $2.3 million in Q3 2022 and fell as low as $1.6 million in Q4 2024.
• The 5-year median for Cost of Revenue is $2.1 million (2024), against an average of $2.0 million.
• Annual changes were most pronounced in 2024 — Cost of Revenue decreased 19.13% — and 2025, when it increased 5.95%.
• A 5-year view of Cost of Revenue shows it stood at $2.1 million in 2022, then declined by 5.38% to $2.0 million in 2023, then declined by 19.13% to $1.6 million in 2024, then rose by 5.95% to $1.7 million in 2025, then fell by 4.48% to $1.7 million in 2026.
• According to Business Quant data, Cost of Revenue over the past three periods registered $1.7 million, $1.7 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.